AtriCure, Inc.
ATRC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,681 | $1,558 | $1,529 | $1,440 |
| - Cash | $148 | $118 | $100 | $123 |
| + Debt | $74 | $77 | $77 | $77 |
| Enterprise Value | $1,607 | $1,518 | $1,506 | $1,393 |
| Revenue | $134 | $136 | $124 | $124 |
| % Growth | -1.4% | 10.1% | -0.5% | – |
| Gross Profit | $101 | $101 | $93 | $93 |
| % Margin | 75.5% | 74.5% | 74.9% | 74.5% |
| EBITDA | $8 | $1 | -$6 | -$9 |
| % Margin | 5.9% | 0.5% | -4.8% | -7.3% |
| Net Income | -$0 | -$6 | -$7 | -$16 |
| % Margin | -0.2% | -4.5% | -5.5% | -12.5% |
| EPS Diluted | -0.01 | -0.13 | -0.14 | -0.33 |
| % Growth | 92.3% | 7.1% | 57.6% | – |
| Operating Cash Flow | $27 | $22 | -$11 | $6 |
| Capital Expenditures | -$3 | -$8 | -$2 | -$15 |
| Free Cash Flow | $24 | $14 | -$13 | -$9 |